Hereditary skin disorder
Therapeutic area
Dermatology
Rare disease
No
- Definition
- An instance of skin disease that is caused by a modification of the individual's genome.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Hereditary skin disorder
- Therapeutic area
- Dermatology
- hereditary skin disorder
- disease, genetic skin
- diseases, genetic skin
- genetic skin disease
- genetic skin diseases
- genodermatosis
- skin disease, genetic
- All therapeutic areas
- Dermatology
- Severity
- Mild
- Genetic
- Hereditary
- MONDO ID
- MONDO:0100118
- Parent condition
- MONDO:0003847
Related records
Broader conditions (8)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of genetic or genomic mechanism
- Hereditary disease
- Human disease
- Integumentary system disorder
- Skin disorder
Narrower conditions (725)
- 22q-related schwannomatosis
- Absence of fingerprints-congenital milia syndrome
- Ackerman syndrome
- Acne
- Acne inversa, familial, 1
- Acne inversa, familial, 2
- Acne inversa, familial, 3
- Acral dystrophic epidermolysis bullosa
- Acral peeling skin syndrome
- Acral self-healing collodion baby
- Acrofacial dysostosis, Weyers type
- Acrogeria
- Acrokeratosis verruciformis
- Acute intermittent porphyria
- Adult acne
- ADULT syndrome
- AKT2-related familial partial lipodystrophy
- Albinism-hearing loss syndrome
- Alopecia - contractures - dwarfism - intellectual disability syndrome
- Alopecia areata 1
Trials (25)
- A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
- A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
- A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
- A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
- A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
- Artificial Intelligence Patient App for RDEB SCCs
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study
- Computational Drug Repurposing for All EBS Cases
- DMT210 Topical Gel in the Treatment of Atopic Dermatitis
- Effect of Benralizumab in Atopic Dermatitis
- Effects of Treatments on Atopic Dermatitis
- Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)
- Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
- Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
- Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong
- Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
- GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment